Sign in

CIK 0000072444

  • Accelerated filer
  • Smaller reporting company

Vaxart, Inc.

Sign in to watch
Ticker
VXRT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
591212264
Phone
+1 650-550-3500
Business address
310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
Former names
Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-04-11 Tucker Sean Chief Scientific Officer Purchase · Common Stock Warrant (right to buy) +27,273 $1.10 $30K 27,273
2019-04-11 Finney Michael J. Director Purchase +181,818 $1.10 $200K 452,572
2019-04-11 Finney Michael J. Director Purchase · Common Stock Warrant +181,818 $1.10 $200K 181,818
2018-09-11 Finney Michael J. Director Other acquisition +34,958 270,754
2018-09-11 Harland John M Chief Financial Officer Other acquisition +761 761
2018-06-05 Finney Michael J. Director Purchase +2,000 $3.46 $7K 231,978
2018-06-05 Finney Michael J. Director Purchase +65 $2.91 $189 232,043
2018-06-05 Finney Michael J. Director Purchase +1,135 $2.92 $3K 233,178
2018-06-05 Finney Michael J. Director Purchase +800 $2.91 $2K 233,978
2018-06-04 Finney Michael J. Director Purchase +1,000 $4.27 $4K 229,978
2018-05-25 Harland John M Chief Financial Officer Grant or award · Stock Option (right to buy) +18,000 18,000
2018-05-25 Latour Wouter President and Chief Executive Grant or award · Stock Option (right to buy) +110,700 110,700
2018-05-25 Tucker Sean Chief Scientific Officer Grant or award · Stock Option (right to buy) +14,000 14,000
2018-03-12 Tucker Sean Chief Scientific Officer Option exercise +2,013 $6.49 $13K 47,653
2018-03-12 Tucker Sean Chief Scientific Officer Option exercise · Stock Option (right to buy) −2,013 0
2018-02-13 Finney Michael J. Director Grant or award +1,818 230,796
2018-02-13 Tucker Sean Chief Scientific Officer Grant or award +45,640 45,640
2018-02-13 Tucker Sean Chief Scientific Officer Grant or award +9,060 9,060
2018-02-13 Tucker Sean Chief Scientific Officer Grant or award +25,388 25,388
2018-02-13 Tucker Sean Chief Scientific Officer Grant or award · Stock Option (right to buy) +2,014 2,014

Page 20 of 23 · 442 trades